Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.000001 USD | 0.00% | +9,900.00% | +9,900.00% |
2020 | Abattis Bioceuticals Corp. Reports Earnings Results for the Full Year Ended September 30, 2019 | CI |
2019 | Abattis Bioceuticals Corp. Announces Board Changes | CI |
Sales 2018 | 8.37K 6.14K | Sales 2019 | 357K 262K | Capitalization | 8.62M 6.32M |
---|---|---|---|---|---|
Net income 2018 | -78M -57.23M | Net income 2019 | -3M -2.2M | EV / Sales 2018 | 5,778 x |
Net cash position 2018 | 9.1M 6.67M | Net cash position 2019 | 2.25M 1.65M | EV / Sales 2019 | 17.8 x |
P/E ratio 2018 |
-0.57
x | P/E ratio 2019 |
-2.8
x | Employees | - |
Yield 2018 * |
-
| Yield 2019 |
-
| Free-Float | 99.64% |
Managers | Title | Age | Since |
---|---|---|---|
Director of Finance/CFO | - | 19-03-31 | |
Patrick Mitchell
COO | Chief Operating Officer | - | 18-10-31 |
Jonathan Danieli
IRC | Investor Relations Contact | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Cedric Wilson
BRD | Director/Board Member | - | 18-10-18 |
Patrick Mitchell
COO | Chief Operating Officer | - | 18-10-31 |
Director of Finance/CFO | - | 19-03-31 |
1st Jan change | Capi. | |
---|---|---|
+9,900.00% | 476 | |
-.--% | 339M | |
+40.21% | 289M | |
+42.80% | 280M | |
+44.19% | 188M | |
+150.49% | 146M | |
+49.96% | 136M | |
-37.59% | 129M | |
-28.57% | 121M | |
+11.54% | 97.22M |
- Stock Market
- Equities
- ATTBF Stock